课题基金 / 基金详情

AIDS-DEMENTIA DUE TO GP120 HOMOLOGY TO NEUROLEUKIN

AIDS-DEMENTIA DUE TO GP120 HOMOLOGY TO NEUROLEUKIN
由于 GP120 与神经白细胞同源性而导致的艾滋病-痴呆症
批准号:
3410307
负责人:
Mark E Gurney
金额:
$14.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-07-01 至 1990-06-30

项目摘要

项目成果

Mark E Gurney的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Neuroleukin is a polypeptide factor which exhibits both neurotrophic and lymphokine activities. A region of the GP120 external envelope protein of HIV is partially homologous to neuroleukin. The homology is to a segment of the ENV gene which is conserved in all HIV isolates for which sequence information has been reported. Recombinant neuroleukin supports the continued survival in culture of spinal and sensory neurons. Message encoding neuroleukin is expressed in brain and we hypothesize that neuroleukin is important for the growth and function of neurons within the CNS. Neuroleukin is also a lymphokine. It is a lectin-stimulated T-cell product and acts to induce immunoglobulin synthesis by cultured human peripheral blood mononuclear cells. We hypothesize that the sequence homology of GP120 to neuroleukin contributes to the subacute encephalitis and to the polyclonal B-cell activation seen in AIDs. Our initial experiments indicate that the GP120 protein has neuroleukin-agonist/antagonist activity and that the activity resides in the neuroleukin-homology segment. To extend our work, we propose to determine if fragments of GP120 which contain the neuroleukin homology segment are encephalitic in animals. We also will show that the pathological effects of GP120 fragments are due to a neuroleukin-dependent mechanism, and that that mechanism involves agonist/antagonist interaction with the neuroleukin receptor on neurons. The project could lead to development of a therapeutic agent and/or a peptide vaccine against HIV.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PDE4B Inhibitors for Treating Brain Injury
  • 批准号:
    8978647
  • 项目类别:
  • 资助金额:
    $22.5万
  • 财政年份:
    2015
  • 负责人:
    Mark E Gurney
  • 依托单位:
BPN14770 Phase 1 Single Ascending Dose Clinical Trial in Healthy Subjects
  • 批准号:
    9077367
  • 项目类别:
  • 资助金额:
    $69.47万
  • 财政年份:
    2015
  • 负责人:
    Mark E Gurney
  • 依托单位:
PDE4D PET Ligand for Psychiatric Disease
  • 批准号:
    8904221
  • 项目类别:
  • 资助金额:
    $34.62万
  • 财政年份:
    2015
  • 负责人:
    Mark E Gurney
  • 依托单位:
PDE4D Allosteric Modulators for Treating Cognitive Impairment
  • 批准号:
    8620810
  • 项目类别:
  • 资助金额:
    $5.37万
  • 财政年份:
    2013
  • 负责人:
    Mark E Gurney
  • 依托单位:
海外基金